Skip to main content
. 2018 May 5;103(3):278–288. doi: 10.1007/s00223-018-0427-z

Table 4.

Characteristics of women with SSRI treatment and matched controls

SSRI No (n = 344) SSRI Yes (n = 86) p
Age (years) 78.0 ± 1.6 77.9 ± 1.6 0.47
Height (cm) 162.8 ± 6.1 162.5 ± 5.8 0.78
Weight (kg) 70.0 ± 13.1 69.7 ± 11.7 0.84
Appendicular lean mass index (kg/m2) 6.64 ± 0.94 6.51 ± 0.80 0.25
Fat mass (kg) 27.6 ± 8.10 27.4 ± 7.29 0.81
Age at menopause (years) 50.1 ± 4.8 50.2 ± 4.1 0.80
Physical activity score (PASE) 105 ± 49.5 92.9 ± 52.0 0.05
Calcium intake (mg/day) 685 ± 369 733 ± 411 0.30
MCS 54.9 ± 8.3 48.8 ± 11.3 < 0.001
PCS 44.7 ± 11.3 42.0 ± 10.9 0.04
Fall accident last year, % (n) 31.1 (107) 39.5 (34) 0.14
Hyperthyreodism, % (n) 5.5 (19) 7.0 (6) 0.61
Hypothyreodism, % (n) 14.3 (49) 10.5 (9) 0.35
Diabetes, % (n) 7.6% (26) 11.6% (10) 0.22
Glucocorticoids p.o., % (n) 2.6 (9) 1.2 (1) 0.69a
Parkinson’s disease, % (n) 1.2 (4) 1.2 (1) 1.00a
Rheumatoid arthritis, % (n) 4.9 (17) 2.3 (2) 0.29
Prior stroke, % (n) 12.8 (44) 15.1 (13) 0.57
Current smoking, % (n) 5.5 (19) 5.8 (5) 0.92
Previous fracture, % (n) 40.1 (138) 37.2 (32) 0.62
Heredity of hip fracture, % (n) 16.3 (56) 18.6 (16) 0.61
High alcohol intake, % (n) 0.3 (1) 2.3 (2) 0.10a
Chronic liver disease, % (n) 0.3 (1) 1.2 (1) 0.36a
Celiac disease, % (n) 1.2 (4) 1.2 (1) 1.00a

Statistically significant values (p < 0.05) are given in bold

An independent samples t test was used to compare differences in continuous variables between matched SSRI-users and non-users. Proportions for dichotomous variables were compared by chi-square test or Fisher’s exact test for small sample sizes. High alcohol intake was defined as more than three standard drinks per day

SSRI selective serotonin reuptake inhibitors, MCS mental health component scale, PCS physical health component scale. Previous fracture fracture after the age of 50

aFisher’s exact test